Introduction
It is now well-established that, in a number of photoperiodic species, including the short-day breeding sheep, the pineal gland plays an important role in the transduction of photoperiodic information (Lincoln, 1979; Bittman, Dempsey & Karsch, 1983) . Pinealectomy abolishes the repro¬ ductive response to artificial winter photoperiod applied in summer to ewes (Bittman et al, 1983) although in the long term pinealectomized ewes show annual variations in reproductive function (Matthews, Kennaway & Seamark, 1981) when kept under field conditions and exposed to annual environmental cues. Appropriate melatonin administration, by feeding (Kennaway, Gilmore & Seamark, 1982a; Arendt, Symons, Laud & Pryde, 1983) , injection (Nett & Niswender, 1982) or infusion (Bittman & Karsch, 1984) , is equipotent with photoperiod in its effects on the reproductive axis. The artificial generation of melatonin profiles mimicking those found during short or long days (Rollag, O'Callaghan & Niswender, 1978; Arendt, Symons & Laud, 1981) will invoke an appropriate response in pinealectomized ewes, regardless of ambient photoperiod (Bittman et al, 1983) . This work strongly supports the concept that the duration of melatonin secretion is the primary factor in the transduction of photoperiodic information in sheep.
Constant-release implants of melatonin in intact rams will induce early testicular growth if given after a period of long days but not if given during exposure to short days (Lincoln & Ebling, 1985) . In intact prepubertal, or adult lactating ewes, vaginal implants will advance onset of oestrus if treatment is begun in July but not in May (Nowak & Rodway, 1985) . These short-day effects of melatonin implants are difficult to interpret in mechanistic terms.
To clarify further the response of the ewe to melatonin administered in different ways, we have compared the time course of the reproductive response of adult maiden ewes to melatonin given as a subcutaneous implant in April, May and June, with the effect of daily melatonin feeding. (Boland, Foulkes, MacDonell & Sauer, 1985; Sauer, Foulkes, Worsfold & Morris, 1986) , using an antiserum raised in sheep against progesterone-11-hemisuccinate conjugated to ovalbumen (Guildhay Antisera, Guildford, Surrey; antiserum no. HP/S/645-IVd). The assay is direct, uses alkaline phosphatase as the enzyme label and disodium p-nitrophenyl phosphate as the substrate. Enzyme activity was assessed by spectrophotometry. Aliquants (10 µ ) of the sheep plasma were assayed in duplicate and the standard curve was con¬ structed by adding progesterone to wether plasma over the range 0-6-34 nmol/1. The limit of detection of the assay, defined as the level of progesterone causing a drop in optical density of two standard deviations from the zero point of the standard curve, was 0-6 nmol/1. The assay was vali¬ dated for use in sheep plasma by cross-reactivity studies, and by parallelism using wether plasma to which progesterone had been added. The only compounds with detectable cross-reactivity were corticosterone (3-5%), 5a-pregnane-3,20-dione (2-8%), 17-hydroxyprogesterone (0-5%) and preg¬ nenolone (0-25%). None of these compounds occur at high enough levels in the plasma under physiological conditions to interfere substantially with the assay. The mean inter-assay variations on pools containing 2-5, 5-9 and 12-5 nmol progesterone/1 were 14-6, 5-4 and 3-6% respectively and intra-assay variations of the same pools were 9-3, 5-8 and 3-2% respectively.
The date of onset of oestrous activity was taken to be the date of the first of two successive plasma samples to give a progesterone value above 3-2 nmol/1, assuming that this was followed by two cycles, each of which had two successive plasma samples with progesterone concentrations of > 3-2 nmol/1.
Melatonin profiles. Plasma melatonin concentrations were measured by a direct radioimmuno¬ assay adapted from one previously described for human plasma (Fraser, Cowen, Franklin, Franey & Arendt, 1983) . The antiserum was raised in the sheep against jV-acetyl-5-methoxytryptophan conjugated to thyroglobulin (Guildhay Antisera, Guildford, Surrey; antiserum no. G/S/704/189-160779) and the standard curve was constructed using charcoal-stripped pooled plasma obtained from at least 4 ewes which had been kept in daylight for at least 6 h before sampling. The assay was validated for use with sheep plasma by assessing parallelism of three pools of plasma obtained during the dark phase and thus containing high levels of melatonin. The recovery of melatonin added to daytime (low melatonin) sheep plasma was 96 ± 12%, 105 ± 3% and 101 ± 7% for pools containing 43, 430 and 860 pmol melatonin/1 respectively (mean ± s.e.m., = 10). The plasma melatonin concentrations in 20 samples covering the normal range (40-1290 pmol/1) using this assay were compared with those obtained for the same samples but using an assay in which melatonin was extracted from the plasma by chloroform (Arendt, Wetterberg, Heyden, Sizonenko & Paunier, 1977) . The correlation between these two methods gave a coefficient (r) of 0-93 and a slope of 0-89, the extraction assay tending to give slightly lower results. The assay sensitivity, defined as that mass of melatonin which produced a drop in binding to the antiserum of two standard deviations of the total binding, was between 12 and 22 pmol/1. The major cross-reacting substances are /V-acetyl tryptamine (0-97%), 6-hydroxymelatonin (0-38%) and 7V-acetyl tryptophan (0-26%). The mean inter-assay variations on plasma pools containing 43, 448 and 1129 pmol melatonin/1 were 131, 50 and 2-6% respectively whilst mean intra-assay variations on pools con¬ taining 103, 677 and 1603 pmol/1 were 8-6, 7-6 and 4-3% respectively. All AU three treatments designed to extend the duration of high melatonin levels (implant insertion, feeding and long darkness), when applied from mid-June, advanced oestrus onset compared to untreated controls in natural light (Fig. 2) . Taking the start of treatment (18 June) as Day 1, the mean (+ s.e.m.) onset of oestrus occurred on Day 62 ± 10 in melatonin-fed ewes, Day 64 + 5 in those with a melatonin implant, Day 72 + 6 in those in 8L:16D and Day 114 ± 4 in untreated con¬ trols. The three treated groups differed significantly from the control group in this respect at < 0-01 (melatonin fed), P< 0001 (melatonin implant) and P<0005 (8L:16D), but did not differ significantly from each other.
The time of onset of oestrus in the ewes given implants in April and May was very variable (Fig. 2) Nett & Niswender (1982) indicated that melatonin treatment in January (late afternoon injection) was ineffective in advancing oestrus. Nowak & Rodway (1985) have reported that vaginal implants of melatonin in May in lactating or prepubertal ewes were ineffective in advancing oestrus in contrast to implants in July, although exhaustion of the implant or lactation itself could have explained the lack of response in May. The experiments reported here suggest that in non-lactating ewes the effect of a melatonin implant is also dependent on the time of administration, and that this effect is probably not explained by exhaustion of the implant.
It appears that ewes must be exposed to a set minimum period of long days before they are able to respond to short days either by early pubertal development or by early onset of ovarian cycles in adults (Foster, 1983) . In rams, prior exposure to long days is also necessary before rams can respond to melatonin implants and show sexual redevelopment (Lincoln & Ebling, 1985) . Failure of melatonin to advance onset of oestrus in ewes treated in January (Nett & Niswender, 1982) , May (Nowak & Rodway, 1985) (Rollag et al, 1978) . Alternatively, the duration of melatonin secretion has been strongly implicated as the effector of photoperiodic response (Carter & Goldman, 1983; Bittman & Karsch, 1984) . Presumably melato¬ nin implants may indicate a very short day as suggested by Lincoln & Ebling (1985) . As yet it has not been possible to distinguish between these two possible mechanisms in sheep and a combination of both is not impossible.
The subcutaneous melatonin implants described here cannot, for technical reasons, be con¬ sidered a suitable method for advancing the breeding season in ewes under field conditions, but some other means of maintaining high plasma melatonin concentrations in plasma from mid-June should prove of practical interest. Certainly daily administration at a set time is unnecessary. After the advance of one seasonal cycle in our June-treated animals, it will be of interest to determine the subsequent sensitivity to melatonin in the following year.
